PACIFIC COAST CABLING 3 - 2004 - Laserfiche WebLink

Home Browse Search

I I I I amgen I I I Amgen 1840 Dehavilland Drive Thousand Oaks, California 91320 amgen.com industry biotechnology I I I contact Vic Tejera, Sr. Network Analyst 805.447.3522 vtejera@amgen.com Amgen has been a client since 1999. I In January 1999, Pacific Coast Cabling was awarded an on-site communication maintenance services contract. In June 2000, Pacific Coast Cabling successfully earned the renewal of the contract for an additional three years. Pacific Coast Cabling provides all labor, material, and equipment associated with communication maintenance services for the Amgen Corporate Center, a campus consisting of 37 buildings spread throughout 120 acres. Pacific Coast Cabling employs two supervisors and 12 on'site, full-time technicians conducting various MAC (moves, adds, changes) and small projects. I I Pacific Coast Cabling maintains its Avaya SYSTIMAX Structured Connectivity Solution. The system consists of a large campus-wide fiber optic and voice backbone, fiber-to-the-desk, and a horizontal cabting system supporting voice and data up-to-Gigabit performance. I I Pacific Coast Cabling closely monitors all daily activities by utilizing the Amgen Work Order Tracking System. Complete documentation is provided to Amgen via electronic and hard copy voice and data circuit schedules for the entire cable plant. Since Pacific Coast Cabling is an Avaya BusinessPartner and certified installer, all installations are certified under the Avaya 25- year warranty and applications assurance program. Pacific Coast Cabling has completed up to 1,800 work orders per month, with each technician completing an average of more than nine work orders a day. Pacific Coast Cabling was selected based on the company's outstanding reputation in the industry, high-caliber of personnel, quality of work, professionalism, responsiveness, and attention to detail. I I I I I About Amgen Amgen is a global biotechnology company that discovers, develops, manufactures and markets important human therapeutics based on advances in cellular and molecular biology. Amgen is #403 in FORTUNE 500; on the sap 500 Index; and #54 on the Financial Times Global 500, comprised of the world's largest companies.